Career opportunities within science and technology are seeing unprecedented growth across the world, and those who study chemistry or another natural science at university now have increasingly better career prospects. In a document, author is GARCIA, G, introducing its new discovery. Recommanded Product: 3-(Methoxycarbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid.
RISPERIDONE – AN ATYPICAL AGENT APPROVED AS 1ST-LINE THERAPY FOR MANAGING MANIFESTATIONS OF PSYCHOTIC DISORDERS
Risperidone, a benzisoxazole derivative, was recently approved by the FDA for the management of psychotic disorders. It joins clozapine as the second antipsychotic agent to become available that possesses both dopaminergic and serotoninergic blocking activities. Risperidone has been shown to improve the positive and negative symptoms of schizophrenia in clinical trials. The drug can be used as a first-line agent and trials are currently being conducted to establish its benefit in treatment-refractory patients. Risperidone is associated with a low incidence of extrapyramidal symptoms, has not been associated with tardive dyskinesia, and does not require hematological monitoring. The availability of risperidone represents progress not only in the pharmacotherapy of schizophrenia, but also in the understanding of the pathophysiology of this disorder.
Interested yet? This just the tip of the iceberg, You can reading other blog about 83249-10-9, Recommanded Product: 3-(Methoxycarbonyl)bicyclo[1.1.1]pentane-1-carboxylic acid.
Reference:
Benzisoxazole – Wikipedia,
,Benzisoxazole – an overview | ScienceDirect Topics